Designing of Anti-Cancer Drug Targeted to Bcl-2 Associated Athanogene (BAG1) Protein
None
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2011
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/22517 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Designing of Anti-Cancer Drug Targeted to Bcl-2 Associated Athanogene (BAG1) Protein
- Anti Oxidative, Anti Peroxidative and Hepatoprotective Potential of Phyllanthus amarus Against Anti Tb Drugs
- Induction of Autophagic Cell Death by Targeting Bcl-2 as a Novel Therapeutic Strategy in Breast Cancer
- Prostate and Colon Cancer Stem Cells as a Target for Anti-Cancer Drug Development
- The Anti-Cancer Effects of Anti-Parasite Drug Ivermectin in Ovarian Cancer
- Introductory Chapter: Protein Kinases as Promising Targets for Drug Design against Cancer
- Unbiased Identification of Extracellular Protein–Protein Interactions for Drug Target and Biologic Drug Discovery